Pregnancy and con- traception in heart disease and pulmonary arterial hypertension. J Fam Plann Reprod Health Care. 2006;32:75 81. S3.13.1-17. Drenthen W, Pieper PG, van der Tuuk K, et al. Fertility, pregnancy and delivery in women after biventricular repair for double outlet right ventricle. Cardiology. 2008;109:105 9. S3.13.1-18. Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol. 2007;49:2303 11. S3.13.1-19. Pedersen LM, Pedersen TAL, Ravn HB, et al. Outcomes of pregnancy in women with tetralogy of Fallot. Cardiol Young. 2008;18:423 9. S3.13.1-20. Vriend JWJ, Drenthen W, Pieper PG, et al. Outcome of preg- nancy in patients after repair of aortic coarctation. Eur Heart J. 2005;26:2173 8. S3.13.1-21. Kovacs AH, Harrison JL, Colman JM, et al. Pregnancy and contra- ception in congenital heart disease: what women are not told. J Am Coll Cardiol. 2008;52:577 8. S3.13.1-22. Beauchesne LM, Connolly HM, Ammash NM, et al. Coarctation of the aorta: outcome of pregnancy. J Am Coll Cardiol. 2001;38:1728 33. S3.13.1-23. Krieger EV, Landzberg MJ, Economy KE, et al. Comparison of risk of hypertensive complications of pregnancy among women with versus without coarctation of the aorta. Am J Cardiol. 2011;107:1529 34. S3.13.1-24. Balci A, Sollie-Szarynska KM, van der Bijl AGL, et al. Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart. 2014;100:1373 81. S3.13.1-25. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:e521 643. S3.13.1-26. Cardiovascular disease and use of oral and injectable proges- togen-only contraceptives and combined injectable contracep- tives. Results of an international, multicenter, case-control study. 